NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $115,000 | +10.6% | 216,448 | +40.2% | 0.00% | – |
| Q2 2020 | $104,000 | +160.0% | 154,360 | +117.9% | 0.00% | – |
| Q1 2020 | $40,000 | -85.3% | 70,846 | -65.6% | 0.00% | – |
| Q4 2019 | $272,000 | -72.7% | 205,748 | -58.6% | 0.00% | – |
| Q3 2019 | $995,000 | -72.7% | 497,569 | -66.8% | 0.00% | – |
| Q2 2019 | $3,641,000 | +442.6% | 1,498,333 | +445.1% | 0.00% | – |
| Q1 2019 | $671,000 | +1665.8% | 274,867 | +949.3% | 0.00% | – |
| Q4 2018 | $38,000 | -91.5% | 26,196 | -84.3% | 0.00% | – |
| Q3 2018 | $449,000 | +52.2% | 166,571 | +96.5% | 0.00% | – |
| Q2 2018 | $295,000 | -70.8% | 84,780 | -57.8% | 0.00% | – |
| Q1 2018 | $1,011,000 | +487.8% | 200,869 | +598.7% | 0.00% | – |
| Q4 2017 | $172,000 | – | 28,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |